TrialThe Journal of infectious diseases2024

Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study.

Alain Amstutz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.